Antacid liquid/powders category goes sour

Sales in the antacid liquid/powders category decreased during the 52 weeks ending Jan. 28, 2001, according to Information Resources Inc., Chicago.

Total dollar sales reached $184 million, down 5%. Drugstore sales were $66 million, down 6.9%. Food store sales came to $61 million, a decline of 3.5%. Mass-merchandiser sales declined 4.4%, to $56 million.

Total unit sales in the antacids category decreased across all three outlets by 8.5%, to 36 million. Drugstore unit sales declined 10.8%, to 12 million. Food stores garnered unit sales of 12 million, a drop of 8.4%. Mass-merchandiser unit sales dove 6.4%, to 12 million.

Antacid liquid/powders total dollar sales in drugstores, food stores, and mass-merchandisers for the 52 weeks ending Jan. 28, 2001

Total dollar sales:
$184 million, down 5.0%

Drugstores $66 million, down 6.9%
(35.9% of market)

Food stores $61 million, down 3.5%
(33.4% of market)

Mass-merchandisers $56 million, down 4.4%
(30.7% of market)

Total unit sales:
36 million, down 8.5%

Drugstores 12 million, down 10.8%
(32.4% of market)

Food stores 12 million, down 8.4%
(34.2% of market)

Mass-merchandisers 12 million, down 6.4%
(33.4% of market)

For a look at sales by individual products, see the tables that follow:

Product

Mylanta
Maalox
Private-label
Mylicon
Mylanta Supreme
Gaviscon
Beano
Tagamet HB 200
Riopan Plus
Lactaid
Little Tummy
Gerber

Total $ sales

$46 million
39 million
27 million
22 million
20 million
10 million
3 million
3 million
2 million
2 million
2 million
1 million

Change from year before

-10%
-11.6
- 0.7
+ 1.8
- 6.5
- 2.2
- 9.4
NA
-16.9
- 5.3
+36.9
NA

Product

Mylan
Private-label
Maalox
Mylanta Supreme
Mylicon
Gaviscon
Beano
Tagamet HB 200
Riopan Plus
Lactaid
Little Tummy
Gerber

Total $ sales

9 million
8 million
7 million
4 million
2 million
1 million
528,215
427,614
390,294
237,185
252,022
101,598

Change from year before

-12.7%
- 6.3
-13.4
- 9.8
+2.1
- 3.1
- 7.2
NA
-17
- 6.5
+27.9
NA

Sandra Levy. Antacid liquid/powders category goes sour.

Drug Topics

2001;7.